rxsight.comHealthcareFounded: 1997Funding to Date: $179.84MM
RxSight is the developer of the first and only adjustable intraocular lens (IOL) that is customized after cataract surgery, enabling doctors and patients to predictably optimize vision after cataract surgery through an office based IOL enhancement.
For more details on financing and valuation for RxSight, register or login.
Already registered? Click here to log in
To read this article and more news on RxSight, register or login.
Already registered? Click here to log in.
Forge and SharesPost have teamed up to provide you with an enhanced trading experience.